|

QL1706 Clinical Trials

15 actively recruiting trials

No change since May 2026

Also known as: Cisplatin, GEMOX, Iparomlimab and Tuvonralimab，PSB205, Lenvatinib, Radiation +1 more

Pipeline

Phase 2: 10Phase 3: 2Phase 1/2: 2

Top Sponsors

Tianjin Medical University Cancer Institute and Hospital2
Qilu Pharmaceutical Co., Ltd.2
Fujian Cancer Hospital2
Fudan University2
Wenjin Yin1

Indications

Cancer15
Breast Cancer3
Liver Cancer2
Locally Advanced Rectal Cancer With Liver Metastases1
Liver Disease1

Other15 trials

A Phase II Study of CRT Combined With QL1706 in ESCC Patients

Phase 2

A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer

Phase 3

A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors

Phase 1/2

First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients

Phase 2

Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma

N/A

Iparomlimab and Tuvonralimab (QL1706) for Intermediate Trophoblastic Tumors

Phase 1/2

Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast Cancer

Phase 2

Perioperative Study of Iparomlimab and Tuvonralimab in Resectable NSCLC

Phase 2

QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.

Phase 3

QL1706 Combined With Lenvatinib and GEMOX as First - Line Treatment for Unresectable Biliary Tract Tumors

Phase 2

QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC

Phase 2

QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer

Phase 2

QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast Cancer

Phase 2

SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases

Phase 2

SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.